$PHIO 8-K SEC Filings

Filed On	Filing
13 Oct 2026	8-K: Other Events Critical Manufacturing Milestone Supports Supply Chain Readiness and Planned Phase 2b Clinical Trial Initiation in First Quarter 2027
28 Sep 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Submission of Matters to a Vote of Security Holders WHEREAS, Phio Pharmaceuticals Corp. (the “Company”) maintains the Phio Pharmaceuticals Corp. 2020 Long-Term Incentive Plan, amended and restated on September 11, 2025 (the “Plan”);
14 Sep 2026	8-K: Other Events Phio Announces Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamous Cell Carcinoma
06 Aug 2026	8-K: Results of Operations and Financial Condition
21 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
07 May 2026	8-K: Results of Operations and Financial Condition
08 Apr 2026	8-K: Entry into a Material Definitive Agreement
30 Mar 2026	8-K: Other Events
05 Mar 2026	8-K: Results of Operations and Financial Condition
18 Feb 2026	8-K: Departure/Election of Directors or Officers; Compensation
10 Feb 2026	8-K: Other Events
20 Jan 2026	8-K: Other Events
23 Dec 2025	8-K: Other Events
25 Nov 2025	8-K: Other Events
13 Nov 2025	8-K: Results of Operations and Financial Condition
06 Nov 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
03 Nov 2025	8-K: Other Events
31 Oct 2025	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
15 Sep 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
03 Sep 2025	8-K: Other Events

Comments